Oral Contraceptives and the Risk of Myocardial Infarction
Letter 2001 English
Authors
BT
Bea C. Tanis
MB
Maurice A. A. J. van den Bosch
JK
Jeanet M. Kemmeren
Abstract
1 min read
An association between the use of oral contraceptives and the risk of myocardial infarction has been found in some, but not all, studies. We investigated this association, according to the type of progestagen included in third-generation (i.e., desogestrel or gestodene) and second-generation (i.e., levonorgestrel) oral contraceptives, the dose of estrogen, and the presence or absence of prothrombotic mutations.
Jeanet M. Kemmeren, Bea C. Tanis, Maurice A. A. J. van den Bosch, Edward Bollen, Frans M. Helmerhorst, Yolanda van der Graaf, Frits R. Rosendaal, Ale Algra
.jpg){kind=small}
Discussion(0)
No comments yet. Be the first to comment.